A Pilot Study of Vitamin D Deficiency and Myalgias, Arthralgias and/or Joint Stiffness associated with Letrozole (Femara).
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 02 Feb 2012 Inclusion and exclusion criteria amended from NCT.
- 10 Aug 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.